Phosphorous-31 Magnetic Resonance Spectroscopy of Cervical Cancer Using Transvaginal Surface Coil

Access this Article

Search this Article

Author(s)

    • OBATA Takayuki
    • Department of Medical Imaging, National Institute of Radiological Sciences
    • OHNO Tatsuya
    • Research Center for Charged Particle Therapy, National Institute of Radiological Sciences
    • SUZUKI Yoshiyuki
    • Research Center for Charged Particle Therapy, National Institute of Radiological Sciences
    • IKEHIRA Hiroo
    • Department of Medical Imaging, National Institute of Radiological Sciences
    • SUHARA Tetsuya
    • Brain Imaging Project, National Institute of Radiological Sciences
    • FURUKAWA Shigeo
    • Research Center for Charged Particle Therapy, National Institute of Radiological Sciences
    • TSUJII Hirohiko
    • Research Center for Charged Particle Therapy, National Institute of Radiological Sciences
    • NAKANO Takashi
    • Research Center for Charged Particle Therapy, National Institute of Radiological Sciences

Abstract

We developed a new transvaginal coil tuned for phosphorous-31 and measured its magnetic resonance spectroscopy (<sup>31</sup>P MRS) of uterine cervical cancer. In a 50-year-old woman with uterine cervical cancer (International Federation of Gynecology and Obstetrics [FIGO] stage IIIb), <sup>31</sup>P MRS with the new coil clearly differentiated the low intensity of phosphocreatinine (PCr) and high intensity of phosphomonoester (PME) in tumor from those in muscle. Results suggests that this method will be useful for assessing uterine cervical cancer.<br>

Journal

  • Magnetic Resonance in Medical Sciences

    Magnetic Resonance in Medical Sciences 4(4), 197-201, 2005-12-31

    Japanese Society for Magnetic Resonance in Medicine

Codes

  • NII Article ID (NAID)
    10018088286
  • NII NACSIS-CAT ID (NCID)
    AA11648770
  • Text Lang
    ENG
  • Article Type
    NOT
  • ISSN
    13473182
  • Data Source
    CJP  J-STAGE 
Page Top